ObsEva to Present at the H.C. Wainwright Global Investment 2022 Conference

ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company focused on women's health, announced a corporate update presentation at the H.C.

Rhea-AI Summary

ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company focused on women's health, announced a corporate update presentation at the H.C. Wainwright Global Investment Conference. The event will occur virtually and in Miami, Florida, from May 23 – 26, 2022. The presentation will be available on-demand starting at 10:30 a.m. EST on May 24, 2022. Investors can access the webcast through the H.C. Wainwright conference portal or under the 'Events Calendar' on ObsEva’s website. The company focuses on treatments for uterine fibroids, endometriosis, and preterm labor.

Argus Session date unavailable

+5.41% session move Open Argus

Details

News Market Reaction – OBSV

The recorded move for OBSV in the trading session of this news was +5.41%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GENEVA, Switzerland May 16, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that Company Management will provide a corporate update at the upcoming H.C. Wainwright Global Investment Conference, taking place virtually and in Miami, Florida from May 23 – 26, 2022.

The presentation will be available on-demand through the H.C. Wainwright conference portal, starting at 10:30 a.m. EST on Tuesday, May 24, 2022.

A webcast can be accessed here and will also be accessible under “Events Calendar” in the investors section of ObsEva’s website.

About ObsEva

ObsEva is a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on new therapies for the treatment of uterine fibroids, endometriosis, and preterm labor. ObsEva is listed on the Nasdaq Global Select Market and is traded under the ticker symbol “OBSV” and on the SIX Swiss Exchange where it is traded under the ticker symbol “OBSN”. For more information, please visit www.ObsEva.com

For further information, please contact:
CEO Office contact
Shauna Dillon
shauna.dillon@obseva.ch
+41 22 552 1550

Investor Contact
Katja Bührer
Katja.buhrer@obseva.com

+1 (917) 969-3438

 

Attachment

• Press Release in Pdf

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is ObsEva's corporate update presentation at the H.C. Wainwright Global Investment Conference?

ObsEva's corporate update presentation will take place on May 24, 2022, starting at 10:30 a.m. EST.

Where can I access ObsEva's presentation during the conference?

The presentation can be accessed on-demand through the H.C. Wainwright conference portal and in the 'Events Calendar' section of ObsEva’s website.

What is ObsEva's focus regarding women's health?

ObsEva focuses on developing therapies for women's reproductive health, including treatments for uterine fibroids, endometriosis, and preterm labor.

What stock symbols are associated with ObsEva?

ObsEva is traded on NASDAQ under the ticker symbol 'OBSV' and on the SIX Swiss Exchange under the ticker symbol 'OBSN'.

What dates will the H.C. Wainwright Global Investment Conference take place?

The H.C. Wainwright Global Investment Conference will be held from May 23 to May 26, 2022.